Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Pulmonology · Autoimmune Interstitial Lung Disease–Arthritis Syndrome

Managing Symptoms and Recognizing Red Flags

At a Glance

Autoimmune ILD-arthritis symptoms can be stable, but new fever, a changing cough, falling oxygen, or painful ulcers need same-day review. Severe breathlessness, chest pain, confusion, blue lips, or inability to speak signal an emergency.

Living with an autoimmune interstitial lung disease (ILD) means learning to distinguish between the typical “noise” of your condition and signs that require medical attention. While many symptoms are part of your day-to-day life, knowing how to triage them—categorizing them by urgency—is essential for your safety and peace of mind.

Common Day-to-Day Symptoms

Most people with these conditions will experience a set of “baseline” symptoms that are managed through routine follow-ups. These are generally not emergencies but should be discussed at your next appointment if they change slowly over time [1].

  • Breathlessness on Exertion: Feeling winded while climbing stairs or walking long distances is a hallmark of ILD [2].
  • Dry, Nagging Cough: A persistent cough that doesn’t produce much mucus is common, especially in Antisynthetase Syndrome [3].
  • Joint Stiffness and Pain: Inflammatory arthritis often causes morning stiffness in the hands and feet that improves with movement [4][5].
  • Mechanic’s Hands: The skin on your palms or the sides of your fingers may become thickened, rough, or cracked [6]. While uncomfortable, this is a known feature of the disease and not an emergency unless signs of infection (redness, pus) appear [7].

When to Call for a Same-Day Review

Certain changes are more urgent and should be reported to your pulmonologist or rheumatologist the same day they occur. These often signal a new infection or a “flare” that needs prompt adjustment of your medications [8].

  • New Fever or Chills: A fever can indicate an infection, which may trigger a lung flare, or it may be a sign of the autoimmune disease itself becoming more active [9][10]. Note that if you are on immunosuppression, you may have a serious infection without a fever.
  • Change in Cough: If your dry cough becomes productive (coughing up yellow, green, or bloody mucus), it may signal a respiratory infection or disease worsening [11]. Any significant blood in your sputum (hemoptysis) may require emergency assessment.
  • Drop in Oxygen: If you use a pulse oximeter and notice your oxygen level has persistently dropped below the individualized threshold set by your care team, call your team [12][13].
  • New Skin Ulcers: Small, painful sores on the fingertips, knuckles, or elbows—especially in anti-MDA5 disease—warrant a quick review to prevent infection and adjust therapy [14].

How to Use a Pulse Oximeter:

  • Rest for a few minutes before taking a reading.
  • Ensure your hand is warm; cold hands can restrict blood flow and give falsely low readings.
  • Wait for a steady reading, rather than taking the first number that flashes.
  • Remember that devices have limitations and can be inaccurate with poor circulation or dark nail polish.
  • Always trust your symptoms. If you are severely breathless, seek help regardless of a “normal” reading.

Red Flags: Emergency Situations

In rare cases, ILD can worsen very quickly. This is sometimes called Rapidly Progressive ILD (RP-ILD) or an Acute Exacerbation (AE-ILD) [15][16]. If you experience any of the following, do not wait for a call back from your doctor; go to the nearest emergency room or call 911/A&E immediately.

  1. Rapidly Worsening Shortness of Breath: If you become severely breathless over hours or days, or if you are short of breath while sitting still [17][18].
  2. Inability to Speak in Full Sentences: Having to stop for breath mid-sentence is a sign of severe respiratory distress [13].
  3. Severe Hypoxia: Oxygen levels that drop persistently near or below 88% (or your individualized emergency threshold) at rest and do not recover with your prescribed supplemental oxygen [19][20].
  4. Chest Pain or Fainting: Sudden chest pain, dizziness, confusion, fainting, or sudden one-sided symptoms [21].
  5. Bluish Tint: A blue or gray color to the lips, tongue, or fingernails [13].

A Note on Anti-MDA5 and RP-ILD

Patients with the anti-MDA5 antibody are at a statistically higher risk for a specific type of rapid progression, particularly in the first months after diagnosis [17]. In this group, the immune system can cause intense lung inflammation very quickly. While having the antibody does not mean you will definitely develop RP-ILD, any new fever or increase in breathlessness should be treated with extreme caution and immediate medical evaluation [22][23].

Triage Summary Table

Urgency Symptoms Action
Emergency Severe breathlessness at rest, inability to speak full sentences, chest pain, blood in cough, confusion. Call 911 / Go to ER
Same-Day New fever, significant drop in oxygen below threshold, new skin ulcers. Call your specialist’s office immediately
Routine Mild joint pain, “mechanic’s hands,” stable cough, expected breathlessness on stairs. Note for your next scheduled visit

Common questions in this guide

Which autoimmune ILD-arthritis symptoms mean I should seek emergency care?
Call 911 or go to an emergency department for rapidly worsening breathlessness, shortness of breath at rest, inability to speak in full sentences, chest pain, fainting, confusion, or blue or gray lips, tongue, or fingernails. Persistent oxygen near or below 88% at rest that does not improve with prescribed oxygen is also an emergency, unless your care team has given you a different emergency threshold.
When should I contact my specialist on the same day?
Call your pulmonologist or rheumatologist the same day for a new fever or chills, a cough that becomes productive, an oxygen reading that stays below your individualized threshold, or new painful ulcers on the fingers, knuckles, or elbows. Significant blood in sputum or severe breathlessness should be treated as an emergency, and people taking immunosuppressive medicine may have a serious infection without a fever.
How can I get a more reliable pulse-oximeter reading?
Rest quietly for a few minutes, warm your hand, and wait for the number to become steady before recording it. Cold fingers, poor circulation, and dark nail polish can make readings inaccurate, so use the threshold set by your care team and seek help for severe breathlessness even if the number looks normal.
Does anti-MDA5 make rapidly progressive ILD more likely?
Yes. People with anti-MDA5 antibodies have a higher statistical risk of rapidly progressive ILD, particularly during the first months after diagnosis, but the antibody does not mean rapid progression is certain. New fever or increasing breathlessness warrants immediate medical evaluation.
What symptoms may be part of my usual baseline?
Stable breathlessness with activity, a dry nagging cough, inflammatory joint stiffness or pain that is worse in the morning, and mechanic's hands can occur as day-to-day symptoms. A gradual change or any new fever, mucus, oxygen decline, or skin ulcer should be reported rather than assumed to be your baseline.
What does it mean if my dry cough starts producing mucus?
A new productive cough, especially with yellow, green, or bloody mucus, can signal a respiratory infection or worsening lung disease. Contact your specialist promptly; significant blood in the sputum, severe breathlessness, or other emergency signs requires emergency care.

Get notified when new evidence is published on Autoimmune interstitial lung disease-arthritis syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (23)
  1. 1

    Occurrence of progressive pulmonary fibrosis and its association with survival in connective tissue disease-associated interstitial lung disease: an international retrospective cohort study.

    Guiot J, Teitsma XM, Dimitroulas T, et al.

    Rheumatology international 2026; (46(10)).

    PMID: 42799753
  2. 2

    Interstitial Lung Disease: A Review.

    Maher TM

    JAMA 2024; (331(19)):1655-1665 doi:10.1001/jama.2024.3669.

    PMID: 38648021
  3. 3

    [Clinical and radiological features of adult patients with different antisynthetase syndrome based on serum anti-aminoacyl-tRNA synthetase antibody type].

    Li S, Huang H, Song XY, et al.

    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2017; (40(12)):919-924 doi:10.3760/cma.j.issn.1001-0939.2017.12.011.

    PMID: 29224302
  4. 4

    Review of Pulmonary Manifestations in Antisynthetase Syndrome.

    Ghanbar MI, Danoff SK

    Seminars in respiratory and critical care medicine 2024; (45(3)):365-385 doi:10.1055/s-0044-1785536.

    PMID: 38710221
  5. 5

    Identification and management of interstitial lung disease associated with systemic sclerosis (SSc-ILD), rheumatoid arthritis (RA-ILD), and polymyositis/dermatomyositis (PM/DM-ILD): development of expert consensus-based clinical algorithms.

    Kondoh Y, Bando M, Kawahito Y, et al.

    Expert review of respiratory medicine 2024; (18(6)):447-456 doi:10.1080/17476348.2024.2374910.

    PMID: 38943279
  6. 6

    Checkerboard Hyperkeratosis With Apoptotic Keratinocytes as Features of Mechanic's Hands and Review of the Literature.

    Long V, Joel LHL

    The American Journal of dermatopathology 2026; (48(4)):278-282 doi:10.1097/DAD.0000000000003231.

    PMID: 41849753
  7. 7

    A Case of Dermatomyositis with Coexistence of Positive Anti-MDA5 Antibodies and Anti-SSA/RO52 Antibodies, Combined with Necrotic Skin Ulcers.

    Sun T, Hu ZH, He JS, et al.

    International medical case reports journal 2024; (17()):9-15 doi:10.2147/IMCRJ.S441691.

    PMID: 38205150
  8. 8

    Value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in acute exacerbation of fibrosing interstitial lung disease: an individualized treatment protocol based on microbiological evidence.

    Zhan S, Li S, Cao Y, et al.

    BMC pulmonary medicine 2024; (24(1)):400 doi:10.1186/s12890-024-03216-1.

    PMID: 39164677
  9. 9

    Clinical characteristics of anti-MDA5 antibody-positive interstitial lung disease.

    Kaenmuang P, Navasakulpong A

    Respirology case reports 2021; (9(1)):e00701 doi:10.1002/rcr2.701.

    PMID: 33343905
  10. 10

    Acute exacerbation of interstitial lung disease associated with rheumatic disease.

    Luppi F, Sebastiani M, Salvarani C, et al.

    Nature reviews. Rheumatology 2022; (18(2)):85-96 doi:10.1038/s41584-021-00721-z.

    PMID: 34876670
  11. 11

    Procalcitonin in acute exacerbation of interstitial lung disease: A systematic review of current evidence.

    Srivali N, De Giacomi F

    Heart & lung : the journal of critical care 2025; (73()):221-227 doi:10.1016/j.hrtlng.2025.05.014.

    PMID: 40482597
  12. 12

    CT predictors of outcomes in patients with connective tissue disease and progressive lung fibrosis.

    Shou AY, Salvatore MM

    Clinical imaging 2023; (94()):42-49 doi:10.1016/j.clinimag.2022.11.022.

    PMID: 36493681
  13. 13

    Interstitial Lung Disease: A Focused Review for the Emergency Clinician.

    Constantino K, Gottlieb M, Long B

    The Journal of emergency medicine 2023; (64(2)):156-166 doi:10.1016/j.jemermed.2022.10.015.

    PMID: 36707347
  14. 14

    Predictive factors for anti-MDA5 antibody in patients with dermatomyositis: a retrospective multicenter study.

    Castellanos-Gonzalez M, Bris BB, Marsol IB, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023; (21(7)):741-748 doi:10.1111/ddg.15089.

    PMID: 37218533
  15. 15

    [Value of serum YKL-40 in the diagnosis of anti-MDA5-positive patients with dermatomyositis complicated with severe pulmonary injury].

    Zhang PL, Yang HX, Zhang LN, et al.

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2021; (53(6)):1055-1060.

    PMID: 34916681
  16. 16

    Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.

    Kondoh Y, Cottin V, Brown KK

    European respiratory review : an official journal of the European Respiratory Society 2017; (26(145)) doi:10.1183/16000617.0050-2017.

    PMID: 28954766
  17. 17

    Prognostic analysis of MDA5-associated clinically amyopathic dermatomyositis with interstitial lung disease.

    Wang W, Sun X, Xu Y, et al.

    Immunity, inflammation and disease 2024; (12(6)):e1332 doi:10.1002/iid3.1332.

    PMID: 38934403
  18. 18

    Acute exacerbations of progressive-fibrosing interstitial lung diseases.

    Kolb M, Bondue B, Pesci A, et al.

    European respiratory review : an official journal of the European Respiratory Society 2018; (27(150)) doi:10.1183/16000617.0071-2018.

    PMID: 30578331
  19. 19

    Oxygen in patients with fibrotic interstitial lung disease: an international Delphi survey.

    Lim RK, Humphreys C, Morisset J, et al.

    The European respiratory journal 2019; (54(2)) doi:10.1183/13993003.00421-2019.

    PMID: 31097522
  20. 20

    Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.

    Visca D, Mori L, Tsipouri V, et al.

    The Lancet. Respiratory medicine 2018; (6(10)):759-770 doi:10.1016/S2213-2600(18)30289-3.

    PMID: 30170904
  21. 21

    Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.

    Moua T, Westerly BD, Dulohery MM, et al.

    Chest 2016; (149(5)):1205-14.

    PMID: 26836940
  22. 22

    Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis.

    Xu Y, Yang CS, Li YJ, et al.

    Clinical rheumatology 2016; (35(1)):113-6 doi:10.1007/s10067-015-3139-z.

    PMID: 26660480
  23. 23

    Clinical Characteristics and Outcomes of Patients with Anti-MDA5 Antibody Associated Rapidly Progressive Interstitial Lung Disease (RP-ILD): A Case Series.

    Gangadharan H, Seetha AP, Musthafa S, et al.

    Mediterranean journal of rheumatology 2024; (35(4)):668-679 doi:10.31138/mjr.020324.cco.

    PMID: 39886293

This page is for informational purposes only and does not constitute medical advice. It explains symptom triage for autoimmune ILD-arthritis syndrome; follow your care team's individualized instructions and seek emergency help for severe symptoms.

Guide contents Autoimmune interstitial lung disease-arthritis syndrome
Research & Literature
01 Understanding Autoimmune Lung Disease and Arthritis 03 The Role of Autoantibodies in Disease Assessment